Evidence map›Paper›PMID 18253722›Full record

ReviewNaunyn-Schmiedeberg's archives of pharmacology2008

On the analysis of ligand-directed signaling at G protein-coupled receptors.

Frederick J Ehlert

Abstract readReview
PubMed Publisher
In one paragraph

Review in Naunyn-Schmiedeberg's archives of pharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. 2-Substituted (N)-Methanocarba AACS pharmacology & translational science · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HTJournal of medicinal chemistry · 2022
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Assessment of biased agonism at the ABiochemical pharmacology · 2020
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. A Biased View ofMolecular pharmacology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Frederick J EhlertDepartment of Pharmacology, School of Medicine, University of California, Irvine, CA 92697, USA. fjehlert@uci.edu
University of California, Irvine · US

Funding

Adenylyl cyclases in airway and GI smooth muscleR01HL079166 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI OSTROM, RENNOLDS S · 2006 to 2010
$1.7M
Agonist Activity at G Protein Coupled ReceptorsR01GM069829 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI EHLERT, FRED J · 2005 to 2008
$931k
NHLBI NIH HHS HL079166NIGMS NIH HHS GM69829
6 · The paper itself

Abstract

The phenomenon of "ligand-directed signaling" is often considered to be inconsistent with the traditional receptor theory. In this review, I show how the mathematics of the receptor theory can be used to measure the observed affinity and relative efficacy of protean ligands at G protein-coupled receptors. The basis of this analysis rests on the assumption that the fraction of agonist bound in the form of the active receptor-G protein-guanine nucleotide complex is the biochemical equivalent of the pharmacological stimulus. Consequently, this stimulus function is analogous to the current response of a ligand-gated ion channel. Because guanosine triphosphate (GTP) greatly inhibits the formation of the active quaternary complex, even the most efficacious agonists probably only elicit partial receptor activation, and it seems likely that the ceiling of 100% receptor activation is not reached in the intact cell with high intracellular concentrations of GTP. Under these conditions, the maximum of the stimulus function is proportional to the ratio of microscopic affinity constants of the agonist for ground and active states. Ligand-directed signaling depends on the existence of different active states of the receptor with different selectivities for different G proteins or other effectors. This phenomenon can be characterized using classic pharmacological methods. Although not widely appreciated, it is possible to estimate the product of observed affinity and intrinsic efficacy expressed relative to that of another agonist (intrinsic relative activity) through the analysis of the concentration-response curves. No other information is required. This approach should be useful in quantifying agonist activity and in converting the two disparate parameters of potency and maximal response into a single parameter dependent only on the agonist-receptor-effector complex.

Indexed as

Models, BiologicalAnimalsGuanosine TriphosphateHumansIon Channel GatingIon ChannelsLigandsReceptors, G-Protein-CoupledSignal TransductionGuanosine TriphosphateIon ChannelsLigandsReceptors, G-Protein-Coupled

Identifiers

PMID18253722
OpenAlexW2036801804

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.